Commencing Clinical Trials

Commencing Clinical Trials

The Alpha DaRT cancer treatment is currently examined in clinical trials for Skin Cancer and Head and Neck Cancer in Israel and in Italy. Clinical trials that are not ongoing are planned to be launched throughout 2019 and 2020 depending on the receipt of regulatory approvals.


In collaboration with major cancer centers in North America, Europe, and Asia, the following cancer indications will be examined in clinical trials:


  • Vulva Cancer (Europe)

  • Prostate Cancer (North America, Europe)

  • Breast Cancer (Europe)

  • Pancreatic Cancer (North America)

  • Skin Cancer, SCC, CMN (North America, Europe)

  • Head and Neck Cancer (North America, Europe)


The Alpha TAU team is preparing additional trials for further indications.


  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

Looking for clinical trials?